drugset / Trial / NCT02678767
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Phase 2
Completed
30 enrolled
Beau Nakamoto
Hawaii Pacific Health · collabNational Institute of Neurological Disorders and Stroke (NINDS) · collabUniversity of Hawaii · collab
Non-randomizedSingle-groupOpen-labelScreening
Summary
This project will investigate the ability of a novel MRI contrast agent to identify and quantitate ongoing monocyte/macrophage (M/MΦ)-mediated inflammation in the brains of HIV-infected individuals.
Timeline
- Start
- 2015-02
- Primary completion
- 2017-09
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferumoxytol | Diagnostic / imaging agent | 4 mg/kg | Intravenous |